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Intrasinusoidal bone marrow infiltration
and splenic marginal zone lymphoma:
a quantitative study
Intrasinusoidal infiltration (ISI) is a recently rec-
ognised pattern of bone marrow (BM) invasion
rarely found in BM biopsies performed for diag-
nostic or staging purpose (1). This peculiar feature
was described to be associated with rare entities,
that share a distinctive intravascular growth pat-
tern, such as the intravascular large B-cell lym-
phoma (malignant angioendotheliomatosis) (2) and
the hepatosplenic cdT-cell lymphoma (3). Subse-
quently, ISI was reported to be a very frequent type
of marrow invasion in patients with splenic margi-
nal zone cell lymphoma (SMZL) with or without
villous lymphocytes (4–8), and was regarded as a
possible hallmark of the disease (4, 6).
Splenic marginal zone cell lymphoma (with or
without villous lymphocytes) is a chronic B-cell
lymphoproliferative disorder (9), that usually has
an indolent course. The diagnosis of SMZL, as
well as of other types of primary splenic lym-
phoma (PSL), should be established after splen-
ectomy, although a clinical diagnosis is also
possible from the analysis of peripheral blood in
cases with circulating elements. However, splen-
ectomy may induce a worsening of BM infiltra-
tion in patients with SMZL (10). Therefore, it
would be very helpful if the pattern of invasion
could allow a reliable diagnosis of SMZL on BM
biopsy.
Unfortunately, intrasinusoidal BM infiltrates
have also been described in other small B-cell
lymphomas, such as follicular lymphoma (FL) and
chronic lymphocytic leukaemia (CLL) (11), mantle
cell lymphoma (MCL) (11, 12) and hairy cell
leukaemia (11, 13), as well as in anaplastic large B-
cell lymphoma, intravascular large B-cell lymphoma
and T large granular lymphocyte leukaemia (7).
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As it has been claimed that a prominent intra-
sinusoidal infiltrate is a distinctive pattern of BM
infiltration in patients with SMZL (10, 11), whereas
an association of ISI with other patterns of BM
infiltration has also been described in different
NHL types, it appears of great importance to
exactly quantify the extent of the intrasinusoidal
infiltrate.
In the present study, we analysed 54 BM biopsies
showing intrasinusoidal infiltration by means of a
quantitative approach. The purpose was to verify if
ISI quantity on BM biopsy could represent a
reliable diagnostic criterion for SMZL.
Materials and methods
All BM biopsies performed in patients with non-
Hodgkin lymphoma (NHL) from 1998 to 2002
were retrieved from the files of the Section of
Pathology of the Department of Biomedical Sci-
ences and Human Oncology of Turin University.
Of a total of 1325 cases showing marrow infiltra-
tion, 54 (4.07%) consecutive and initial BM biop-
sies with intrasinusoidal infiltration were selected.
Twenty-nine patients were females (53.7%) and
25 (46.3%) males. The mean age of patients was
60.2 yr (median, 63; range, 30–79). According to
WHO classification (14), there were 31 (57.4%)
marginal zone lymphoma (MZL), six (11.1%)
MCL, six (11.1%) small lymphocytic lymphoma/
chronic lymphocytic leukaemia (SLL/CLL), four
(7.4%) FL, four (7.4%) diffuse large B-cell lym-
phoma (DLBCL), one (1.9%) peripheral T-cell
lymphoma (PTL), one (1.9%) lymphoplasmacytic
lymphoma (LDL) and one (1.9%) anaplastic large-
cell lymphoma (ALCL). Twenty-five patients
underwent splenectomy: the mean weight of the
spleen was 1722 g (median, 1500; range, 340–4700).
According to Warnke et al. (15), 35 (64.8%) were
primary lymphomas of the spleen (PSL). Fifteen
patients (42.9%) were males and 20 (57.1%)
females. The mean age of patients was 58.5 yr
(median, 61.5; range, 30–79). There were 28 (80%)
SMZL, two (5.7%) MCL, two (5.7%) SLL/CLL,
one (2.9%) DLBCL, one (2.9%) PTL and one
(2.9%) LDL. Twenty-four patients underwent
splenectomy.
Nineteen cases were non-PSL. Ten patients
(52.6%) were males and nine (47.4%) females.
The mean age of patients was 63.3 yr (median, 65;
range, 34–77). There were three (15.8%) MZL, four
(21.1%) FL, four (21.1%) MCL, four (21.1%)
SLL/CLL, three (15.8%) DLBCL and one (5.3%)
ALCL. One patient underwent splenectomy.
The diagnostic material available for subtyping
the lymphomas was represented by surgically
removed lymph nodes, spleen, peripheral blood
and BM aspirates and/or biopsies. Diagnosis was
made based on histologic examination of lymph
nodes, spleen and/or BM integrated with immuno-
phenotypic and cytologic data.
Immunohistochemistry was performed on depa-
raffinised and rehydrated sections, following an
immuno-peroxidase technique with an automatic
stainer device (Dakoautostainer, DakoCytomation,
Glostrup, Denmark), according to manufacturer’s
instructions. Samples were analysed with a mono-
clonal antibody panel comprising: CD3 (Medac,
Wedel, Germany), CD5 (Neomarkers, Fremont,
CA, USA), CD10 (Medac), CD20 (Dako), CD21
(Dako), CD23 (The Binding Site, Birmingham,
UK), CD43 (Becton Dickinson, San Jose´, CA,
USA), Bcl-2 (Dako), Bcl-6 (Dako), Ki-67 (Dako),
p53 (24/28, Medac), cyclin D1 (Neomarkers).
Surface antigens have been studied with a three-
colour operating FACS (FACScalibur, Becton
Dickinson), on mononuclear cells obtained from
lymph nodes or biopsy specimens. The following
monoclonal antibody combinations were used for
analysis of B cells: CD43/CD23/CD19, FMC7/
CD79b/CD19, CD5/CD20/CD45, CD20/CD10/
CD19, kappa/lambda/CD19, CD103/CD22/CD19
and CD25/CD11c/CD19. Antibodies to CD11c and
FMC7 were obtained from Caltag (Burlingame,
CA, USA). Antibodies to CD103 and CD22 were
obtained from IQP (Immunoquality Product,
Groningen, the Netherlands). Antibodies to
CD43 and CD5 were obtained from Immunotech
(Marseille, France). Antibody to CD25 was ob-
tained from Dako. Antibody to CD79b was
obtained from Southern Biotechnology (Birming-
ham, AL, USA). Antibodies to CD19, CD23,
CD20, CD10, CD45, kappa and lambda were
obtained from Becton Dickinson. T cells as a
control population also were evaluated with an
appropriate immunophenotyping panel.
In selected cases, polymerase chain reaction
(PCR) analysis of IgH rearrangements, heterodu-
plex analysis, DNA sequencing and mutational
status analysis, and PCR analysis of Bcl-2/IgH
rearrangement were also performed as previously
described (16).
If a patient did not undergo splenectomy, the
diagnosis of PSL was based on splenomegaly
without lymphadenopathy, and the presence of
clonal (light chain-restricted) circulating CD19/
CD20 positive B lymphocytes that were negative
for CD5, CD10, CD23 and CD43.
All BM biopsies were taken at presentation as a
part of the staging procedure, from both right and
left posterior–superior iliac crests, using a Jamshidi
needle. Biopsies were immediately fixed in buffered
acid formol for 24 h, decalcified in Osteodec
(Bioptica, Milan, Italy) [ethylenediaminetetraacetic
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acid (EDTA), HCl mixture] for 6 h, dehydrated
and embedded in paraffin. Only sections measuring
at least 8 · 2 mm, with a minimum marrow area
(excluding periosteal tissues, cortical bone and
artifacts) of 9 mm2 were included in the study.
Serial sections (3 lm thick) were stained with
haematoxylin–eosin, periodic-acid Schiff (PAS),
Giemsa and reticulin staining. Immunohistochem-
istry was performed in each case. Sections were
deparaffinised in xylene and rehydrated in a series
of graded alcohols. Slides were incubated in
10 mmol/L citrate buffer, pH 6, at 121C in a
steam autoclave. Immunohistochemistry was per-
formed with an automatic stainer device (Dako-
autostainer, Dako), using the Labelled
Streptavidin-Biotin 2 System detection kit (Dako),
diaminobenzidine as chromogen and monoclonal
antibodies anti-CD45, CD20 (Dako) and CD3
(Novocastra, Newcastle, UK). In selected cases,
the analysis was supplemented by monoclonal
antibodies anti-CD79a, CD76 (clone DBA44),
CD8, CD30 (Dako), CD5, CD4 (Novocastra),
TIA-1 (Immunotech), granzyme B (Monosan,
Uden, the Netherlands), and the polyclonal anti-
body anti-ALK (Zymed, San Francisco, CA,
USA). When intrasinusoidal infiltrate was scanty,
BM biopsies were stained with anti-CD34 mono-
clonal antibody (Clone QBEnd/10) (Neomarkers)
to highlight the vascular structure, thus allowing a
more precise quantification of ISI extent.
Evaluation of the extent of BM invasion
In each case, the assessment of the quantity of BM
invasion was independently performed by two
observers (F.F. and A.F.) on CD45, CD20 and
CD3 stained sections, using a Zeiss Axioskop
microscope (Carl Zeiss, Jena, Germany) equipped
with a 10· ocular and a 20· objective.
The mean percentage of CD20 (or CD3 in
peripheral T-cell lymphoma) stained lymphocytes
over the total number of BM nucleated cells,
including lymphoma cells, was calculated by exam-
ining 10 randomly selected areas from both left-
and right-side biopsies for each case. The value was
regarded as the quantity of total invasion (TI) of
the BM. Then, the mean percentage of CD20 (or
CD3 in peripheral T-cell lymphoma)-stained
lymphocytes located within the sinusoidal spaces
in the same areas was calculated for each case. The
value was considered as the quantity of ISI (Figs 1
and 2). The interobserver variation was <5%.
Statistical analysis
Associations between the quantity of BM infiltrate
and the origin of lymphoma (PSL, non-PSL), or the
type of lymphoma were assessed by the two-tailed
t-test (for TI) or the Mann–Whitney U-test (for
ISI). The independence between categorised varia-
bles (patterns of non-ISI infiltration) and the type
of lymphoma in PSL was estimated by the Yates
corrected chi-squared test. The relationship be-
tween continuous variables (TI, ISI) and the weight
of resected spleen was assessed by the linear
correlation (Pearson’s correlation coefficient). All
data were processed with BMDP selected programs
(2D, 3D, 6D, 7D, 4F) (17).
Results
Association between the quantity of BM infiltration
and PSL or non-PSL
The mean TI for the whole series was 26.31
(median, 20; SD ¼ 20.97; range, 1–80). It was
Fig. 1. Bone marrow intrasinusoidal infiltration by splenic
marginal zone lymphoma: the quantity of ISI is about 15%
of all nucleated marrow cells (CD20 immunostaining; ori-
ginal magnification ·250; inset: ·400).
Fig. 2. Bone marrow intrasinusoidal infiltration by splenic
marginal zone lymphoma: the quantity of ISI is about 5%
of all nucleated marrow cells (CD20 immunostaining; ori-
ginal magnification ·400).
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greater in non-PSL (mean, 35.05; median, 25;
SD ¼ 25.25; range, 1–80) than in PSL (mean,
21.57; median, 15; SD ¼ 16.79; range, 5–70)
(P ¼ 0.04).
The mean ISI for the whole series was 6.07
(median, 4.82; SD ¼ 5.29; range, 0.1–21.3). It was
greater (mean, 7.62; median, 7.2; SD ¼ 5.59; range,
0.2–21.3) in non-PSL than in PSL (mean, 5.23;
median, 3.7; SD ¼ 5; range, 0.1–20.1); however, the
difference is only of borderline statistical signifi-
cance (P ¼ 0.08). The results are shown in Table 1.
Association between the quantity of ISI and the type of lymphoma
in PSL and non-PSL
No difference was found between the extent of ISI
and the type of lymphoma in PSL. ISI was 5.83 for
SMZL, 4.1 for splenic SLL/CLL, 3.15 for splenic
MCL, 0.1 for DLBCL, 5 for LDL and 0.26 for PTL
(P ¼ 0.74). The results are shown in Table 2.
No difference was found between the extent of
ISI and the type of lymphoma in non-PSL. ISI was
4.46 for MZL, 7.4 for SLL/CLL, 13.47 for MCL,
6.63 for DLBCL, 5.27 for FL and 7 for ALCL
(P ¼ 0.3). ISI quantity tended to be greater in
MCL than MZL (P ¼ 0.07). When all non-MCL
were grouped in a single category, the difference in
ISI extent between MCL (13.47) and non-MCL
(6.06) was significant (P ¼ 0.03). The results are
reported in Table 3.
Because of the small number of cases of some
categories, all non-SMZL (in PSL) and non-MZL
(in non-PSL) were categorised as a single group.
When all non-SMZL were considered as a single
group, the quantity of ISI was greater in SMZL
than in non-SMZL, although not statistically
different (P ¼ 0.12). No difference in ISI quantity
was also seen between MZL and non-MZL in non-
PSL (P ¼ 0.28). The results are summarised in
Table 4.
Association between the pattern of non-ISI marrow infiltrate
in PSL
None of the different types of small B-cell lym-
phoma showed intrasinusoidal infiltration as the
only expression of BM infiltration. Interestingly,
not even MZL had an exclusive ISI pattern. A
number of patterns of BM infiltration could be seen
in association with ISI in all cases (non-ISI pattern)
(Fig. 3). According to the most currently applied
classification (18–20), the patterns of BM infiltra-
tion associated with ISI were nodular, four cases
(11.2%); interstitial, nine (25.7%); nodular-inter-
Table 1. Quantity of marrow infiltration in primary splenic and non-primary splenic
lymphomas
No. TI (mean € SD) ISI (mean € SD)
Whole series 54 26.31 € 20.97 6.07 € 5.29
Primary splenic 35 21.57 € 16.79 5.23 € 5
Non-primary splenic 19 35.05 € 25.25 7.62 € 5.59
P-value 0.04 0.08
TI, total invasion; ISI, intrasinusoidal invasion.
Table 2. Quantity of intrasinusoidal marrow infiltration in primary splenic
lymphomas according to the lymphoma categories
n Mean € SD
Whole series 35 5.23 € 5
SMZL 28 5.83 € 5.28
SLL/CLL 2 4.1 € 4.8
MCL 2 3.15 € 1.2
DLBCL 1 0.1
LDL 1 5
PTL 1 0.26
P ¼ 0.74.
SMZL, splenic marginal zone lymphoma; SLL/CLL, small lymphocytic lymphoma/
chronic lymphocytic leukaemia; MCL, mantle cell lymphoma; DLBCL, diffuse large B-
cell lymphoma; LDL, lymphoplasmacytic lymphoma; PTL, peripheral T-cell lymphoma.
Table 3. Quantity of intrasinusoidal marrow infiltration in non-primary splenic
lymphomas according to the lymphoma categories
n Mean € SD
Whole series 19 7.62 € 5.59
MZL 3 4.46 € 3.43
SLL/CLL 4 7.4 € 2.01
MCL 4 13.47 € 7.06
DLBCL 3 6.63 € 8.9
FL 4 5.27 € 2.98
ALCL 1 7
P ¼ 0.3; MZL vs. MCL ¼ 0.07.
Considering all non-MCL as a single group, the difference in ISI extent between
MCL (13.47) and non-MCL (6.06) is significant (P ¼ 0.03).
MZL, marginal zone lymphoma; SLL/CLL, small lymphocytic lymphoma/chronic
lymphocytic leukaemia; MCL, mantle cell lymphoma; DLBCL, diffuse large B-cell
lymphoma; FL, follicular lymphoma; ALCL, anaplastic large-cell lymphoma.
Table 4. Association between the quantity of intrasinusoidal marrow infiltration
and the type of lymphoma in primary splenic and non-primary splenic lymphomas
n Mean € SD
Primary splenic
Whole series 35 5.23 € 5
SMZL 28 5.83 € 5.28
Non-SMZL 7 2.83 € 2.79
P-value 0.12
Non-primary splenic
Whole series 19 7.62 € 5.59
MZL 3 4.46 € 3.43
Non-MZL 16 8.21 € 5.79
P-value 0.28
SMZL, splenic marginal zone lymphoma; MZL, marginal zone lymphoma.
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stitial, 19 (54.3%); diffuse, two (5.7%) and inter-
stitial-paratrabecular, one (2.9%).
The distribution of the patterns of marrow
invasion different from ISI was not different
between SMZL and non-SMZL (P ¼ 0.16). The
nodular pattern was present in SMZL only. The
results are shown in Table 5.
Association between the quantity of BM infiltration
and the weight of the spleen in PSL
A direct correlation was found between the weight
of the spleen and TI quantity in patients who
underwent splenectomy (r ¼ 0.41, P ¼ 0.04), while
no correlation was seen between ISI quantity and
the weight of the spleen (r ¼ 0.04, P ¼ 0.84).
Discussion
Intrasinusoidal infiltration is a pattern of invasion
that is rarely found on BM biopsies performed for
diagnostic or staging purpose (1) and is considered
as a hallmark of SMZL with or without villous
lymphocytes (4, 6). In our series, ISI was detected in
only 54 of 1325 consecutive NHL showing marrow
invasion (4.07%). However, although most of the
cases (57%) with ISI were SMZL or non-splenic
MZL, other lymphoma categories, in particular,
SLL/CLL (Fig. 4), MCL (Fig. 5), FL (Fig. 6),
DLBCL, LDL, PTL and ALC also showed intra-
sinusoidal infiltration. This is in accordance with a
recent study reporting that ISI is a common growth
pattern for different lymphoma subtypes (7).
Moreover, intrasinusoidal infiltration was not
the exclusive pattern of BM infiltration in the
different types of small B-cell lymphoma, not even
Fig. 3. Splenic marginal zone lymphoma showing a nod-
ular, interstitial and intrasinusoidal pattern of invasion
(CD20 immunostaining; original magnification ·250).
Table 5. Association between non-intrasinusoidal
patterns of marrow invasion and lymphoma categories
in primary splenic lymphomasN (%) Nodular Interstitial
Nodular
interstitial Diffuse
Interstitial
paratrabecular
Whole
series
SMZL 4 (14.3) 8 (28.6) 15 (53.6) 1 (3.6) 0 28 (100)
Non-SMZL 0 1 (14.3) 4 (57.1) 1 (14.3) 1 (14.3) 7 (100)
Whole series 4 (11.2) 9 (25.7) 19 (54.3) 2 (5.7) 1 (2.9) 35 (100)
v2 ¼ 6.58; P ¼ 0.16.
SMZL, splenic marginal zone lymphoma.
Fig. 4. Bone marrow involvement by B-chronic lymphocy-
tic leukaemia showing intrasinusoidal, interstitial and nod-
ular pattern of infiltration (CD20 immunostaining; original
magnification ·250).
Fig. 5. Bone marrow involvement by mantle cell lym-
phoma. A predominant nodular pattern of infiltration is
associated with intrasinusoidal infiltration (CD20 immu-
nostaining; original magnification ·250).
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in MZL, but it was always associated with other
patterns of infiltration. Moreover, in BM involve-
ment by MZL, an association of a few large B cells
with small cells in the intrasinusoidal infiltration
was occasionally observed (Fig. 7).
A prominent ISI was reported to be character-
istic of SMZL (10, 11). Using strict morphologic
and immunohistochemical criteria, we did not
detect any difference in ISI quantity between PSL
and non-PSL, but rather found that ISI quantity
tended to be greater in non-PSL (7.68) than in PSL
(5.23, P ¼ 0.08). Therefore ISI quantity in BM
biopsy does not allow the distinction between PSL
and non-PSL.
When only PSL were analysed, ISI extent was
greater in MZL type (5.83) than in other types
(2.83); however, the difference is not statistically
significant (P ¼ 0.12) (Table 4). No differences
were also seen among the various lymphoma
categories (P ¼ 0.74) (Table 2). Therefore, ISI
quantity alone does not allow the diagnosis of
SMZL on BM biopsy, and an extensive or
prominent ISI is not a diagnostic criterion. This
is also supported by the lack of correlation between
ISI quantity and the weight of the spleen (r ¼ 0.04,
P ¼ 0.84), whereas a direct correlation was found
between TI quantity and the weight of the spleen
(r ¼ 0.41, P ¼ 0.04).
When non-PSL were considered, ISI quantity
was greater in non-MZL (8.21) than in MZL (4.46),
although not significantly different (P ¼ 0.28)
(Table 4). Interestingly, the four non-splenic MCL
of our series had an ISI quantity (13.47) greater
than the other categories of non-PSL (6.06, P ¼
0.03). The finding is in accordance with a recent
study reporting an extensive intrasinusoidal infil-
tration of BM in two cases of MCL (12).
As far as the patterns of BM infiltration different
fromISI are concerned,Table 5 indicates that inPSL
the nodular pattern was present in SMZL only, in
agreement with reports showing that the most
common finding in BM biopsy of patients with
SMZL is the nodular pattern of infiltration (8, 21).
We are aware that the number of cases of small
B-cell lymphoma is too small to allow a definite
conclusion. However, our results suggest that
although intrasinusoidal infiltration is very fre-
quent in SMZL, ISI quantity alone, as assessed by
strict morphologic and immunohistochemical cri-
teria, is not diagnostic of SMZL, regardless of the
extension. The pathologist should be cautious in
referring the intrasinusoidal BM infiltration to a
SMZL, unless a complete immunophenotype of the
marrow infiltrate is performed.
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